Access cutting-edge autism spectrum disorder treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access autism spectrum disorder specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related autism spectrum disorder treatment provided free
ML-004-002 is a multi-center, randomized, double-blind, parallel-group, placebo-controlled study that will enroll approximately 150 adolescent and adult subjects with ASD. The primary objective is to evaluate the efficacy of ML-004 compared with placebo in the improvement of social communication deficits in subjects with ASD.
Sponsor: MapLight Therapeutics
Check if you qualify for this autism spectrum disorder clinical trial in Washington Dc, DC
If you're searching for autism spectrum disorder treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced autism spectrum disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.